肝門部膽管癌外科治療10年演變_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 程慶保 ,  姜小清 , 易濱 , 吳越 , 張柏和

第二軍醫大學東方肝膽外科醫院膽道外科；第二軍醫大學膽道腫瘤專病診療中心（上海 200438）;

Corresponding?author：

姜小清, Email: jxq1225@sina.com

Keywords：

DOI：

10.7507/1007-9424.20160335

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 程慶保, 姜小清, 易濱, 吳越, 張柏和. 肝門部膽管癌外科治療10年演變. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(11): 1304-1307. doi: 10.7507/1007-9424.20160335 Copy

1.	Cheng QB, Yi B, Wang JH, et al. Resection with total caudate lobec-tomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type Ⅲ and Ⅳ. Eur J Surg Oncol, 2012, 38(12):1197-1203.
2.	Klatskin G. Adenocarcinoma of the hepatic duct atits bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med, 1965, 38:241-256.
3.	Edge SB, Compton CC. The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17(6):1471-1474.
4.	姜小清, 程慶保. 肝門部膽管癌的分型及外科治療. 中國普外基礎與臨床雜志, 2014, 21(3):260-264.
5.	Jarnagin WR, Fong Y, Dematteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg, 2001, 234(4):507-519.
6.	Tilleman EH, de Castro SM, Busch OR, et al. Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg, 2002, 6(3):426-431.
7.	Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparo-scopy in subsets of biliary cancers:laparoscopy is a powerful diagno-stic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc, 2006, 20(5):721-725.
8.	Rous P, Larimore LD. Relation of the portal blood to liver mainten-ance:a demonstration of liver atrophy conditional on compensation. J Exp Med, 1920, 31(5):609-632.
9.	Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embo-lization to increase safety of major hepatectomy for hilar bile duct carcinoma:a preliminary report. Surgery, 1990, 107(5):521-527.
10.	Bhardwaj N, Garcea G, Dennison AR, et al. The surgical management of Klatskin tumours:has anything changed in the last decade? World J Surg, 2015, 39(11):2748-2756.
11.	Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma:analysis of a single-center experience and review of the literature. Liver Transpl, 2001, 7(12):1023-1033.
12.	Hosokawa I, Shimizu H, Yoshidome H, et al. Surgical strategy for hilar cholangiocarcinoma of the left-side predominance:current role of left trisectionectomy. Ann Surg, 2014, 259(6):1178-1185.
13.	Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg, 1999, 230(6):808-819.
14.	Jonas S, Kling N, Guckelberger O, et al. Orthotopic liver transplanta-tion after extended bile duct resection as treatment of hilar cholan-giocarcinoma. First long-terms results. Transpl Int, 1998, 11 Suppl 1:S206-S208.
15.	Rea DJ, Heimbach J K, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiationis more effective than resection for hilar cholangiocarcinoma. Ann Surg, 2005, 242(3):451-461.
16.	Heimbach JK, Gores GJ, Nagorney DM, et al. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy:a new paradigm for liver and biliary malignancies? Surgery, 2006, 140(3):331-334.
17.	Cheng Q, Luo X, Zhang B, et al. Predictive factors for prognosis of hilar cholangiocarcinoma:postresection radiotherapy improves survival. Eur J Surg Oncol, 2007, 33(2):202-207.
18.	Cheng Q, Feng F, Zhu L, et al. Circulating miR-106a is a novel prog-nostic and lymph node metastasis indicator for cholangiocarcinoma. Sci Rep, 2015, 5:16103.
19.	Ou YQ, Zhang S, Cheng QB, et al. Dynamic change of total bilirubin after portal vein embolization is predictive of major complications and posthepatectomy mortality in patients with hilar cholangiocarci-noma. J Gastrointest Surg, 2016, 20(5):960-969.
20.	Yi B, Xu AM, Lai EC, et al. Preoperative portal vein embolization for hilarcholangiocarcinoma-a comparative study. Hepatogastroen-terology, 2010, 57(104):1341-1346.
21.	Ratti F, Cipriani F, Ferla F, et al. Hilar cholangiocarcinoma:preopera-tive liver optimization with multidisciplinary approach. Toward a better outcome. World J Surg, 2013, 37(6):1388-1396.
22.	姜小清, 易濱, 羅祥基, 等. 肝門部膽管癌10年外科治療經驗.中華消化外科雜志, 2010, 9(3):180-182.

1. Cheng QB, Yi B, Wang JH, et al. Resection with total caudate lobec-tomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type Ⅲ and Ⅳ. Eur J Surg Oncol, 2012, 38(12):1197-1203.
2. Klatskin G. Adenocarcinoma of the hepatic duct atits bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med, 1965, 38:241-256.
3. Edge SB, Compton CC. The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17(6):1471-1474.
4. 姜小清, 程慶保. 肝門部膽管癌的分型及外科治療. 中國普外基礎與臨床雜志, 2014, 21(3):260-264.
5. Jarnagin WR, Fong Y, Dematteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg, 2001, 234(4):507-519.
6. Tilleman EH, de Castro SM, Busch OR, et al. Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction. J Gastrointest Surg, 2002, 6(3):426-431.
7. Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparo-scopy in subsets of biliary cancers:laparoscopy is a powerful diagno-stic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc, 2006, 20(5):721-725.
8. Rous P, Larimore LD. Relation of the portal blood to liver mainten-ance:a demonstration of liver atrophy conditional on compensation. J Exp Med, 1920, 31(5):609-632.
9. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embo-lization to increase safety of major hepatectomy for hilar bile duct carcinoma:a preliminary report. Surgery, 1990, 107(5):521-527.
10. Bhardwaj N, Garcea G, Dennison AR, et al. The surgical management of Klatskin tumours:has anything changed in the last decade? World J Surg, 2015, 39(11):2748-2756.
11. Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma:analysis of a single-center experience and review of the literature. Liver Transpl, 2001, 7(12):1023-1033.
12. Hosokawa I, Shimizu H, Yoshidome H, et al. Surgical strategy for hilar cholangiocarcinoma of the left-side predominance:current role of left trisectionectomy. Ann Surg, 2014, 259(6):1178-1185.
13. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg, 1999, 230(6):808-819.
14. Jonas S, Kling N, Guckelberger O, et al. Orthotopic liver transplanta-tion after extended bile duct resection as treatment of hilar cholan-giocarcinoma. First long-terms results. Transpl Int, 1998, 11 Suppl 1:S206-S208.
15. Rea DJ, Heimbach J K, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiationis more effective than resection for hilar cholangiocarcinoma. Ann Surg, 2005, 242(3):451-461.
16. Heimbach JK, Gores GJ, Nagorney DM, et al. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy:a new paradigm for liver and biliary malignancies? Surgery, 2006, 140(3):331-334.
17. Cheng Q, Luo X, Zhang B, et al. Predictive factors for prognosis of hilar cholangiocarcinoma:postresection radiotherapy improves survival. Eur J Surg Oncol, 2007, 33(2):202-207.
18. Cheng Q, Feng F, Zhu L, et al. Circulating miR-106a is a novel prog-nostic and lymph node metastasis indicator for cholangiocarcinoma. Sci Rep, 2015, 5:16103.
19. Ou YQ, Zhang S, Cheng QB, et al. Dynamic change of total bilirubin after portal vein embolization is predictive of major complications and posthepatectomy mortality in patients with hilar cholangiocarci-noma. J Gastrointest Surg, 2016, 20(5):960-969.
20. Yi B, Xu AM, Lai EC, et al. Preoperative portal vein embolization for hilarcholangiocarcinoma-a comparative study. Hepatogastroen-terology, 2010, 57(104):1341-1346.
21. Ratti F, Cipriani F, Ferla F, et al. Hilar cholangiocarcinoma:preopera-tive liver optimization with multidisciplinary approach. Toward a better outcome. World J Surg, 2013, 37(6):1388-1396.
22. 姜小清, 易濱, 羅祥基, 等. 肝門部膽管癌10年外科治療經驗.中華消化外科雜志, 2010, 9(3):180-182.

Previous Article
肝門部膽管癌根治性切除的可能性評估
Next Article
“第四肝門”在圍肝門外科的臨床意義

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肝門部膽管癌外科治療10年演變

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content